As of 2024-09-10, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (151.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.12 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -1352.9%.
The range of the Relative Valuation is (137.48) - (147.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 38.3x | 31.4x |
| Forward P/E multiples | 21.4x - 27.1x | 24.4x |
| Fair Price | (137.48) - (147.72) | (151.85) |
| Upside | -1234.4% - -1318.8% | -1352.9% |
| Date | P/E |
| 2024-09-10 | -2.23 |
| 2024-09-09 | -2.14 |
| 2024-09-06 | -2.12 |
| 2024-09-05 | -2.18 |
| 2024-09-04 | -2.23 |
| 2024-09-03 | -2.32 |
| 2024-08-30 | -2.37 |
| 2024-08-29 | -2.39 |
| 2024-08-28 | -2.40 |
| 2024-08-27 | -2.39 |
| 2024-08-26 | -2.44 |
| 2024-08-23 | -2.41 |
| 2024-08-22 | -2.30 |
| 2024-08-21 | -2.33 |
| 2024-08-20 | -2.29 |
| 2024-08-19 | -2.32 |
| 2024-08-16 | -2.24 |
| 2024-08-15 | -2.25 |
| 2024-08-14 | -2.13 |
| 2024-08-13 | -2.32 |
| 2024-08-12 | -2.27 |
| 2024-08-09 | -2.31 |
| 2024-08-08 | -2.48 |
| 2024-08-07 | -2.27 |
| 2024-08-06 | -2.39 |
| 2024-08-05 | -2.36 |
| 2024-08-02 | -2.55 |
| 2024-08-01 | -2.72 |
| 2024-07-31 | -2.71 |
| 2024-07-30 | -2.71 |
| 2024-07-29 | -2.82 |
| 2024-07-26 | -2.85 |
| 2024-07-25 | -2.82 |
| 2024-07-24 | -2.76 |
| 2024-07-23 | -2.75 |
| 2024-07-22 | -2.70 |
| 2024-07-19 | -2.63 |
| 2024-07-18 | -2.70 |
| 2024-07-17 | -2.91 |
| 2024-07-16 | -2.97 |
| 2024-07-15 | -3.04 |
| 2024-07-12 | -2.94 |
| 2024-07-11 | -2.75 |
| 2024-07-10 | -2.68 |
| 2024-07-09 | -2.65 |
| 2024-07-08 | -2.51 |
| 2024-07-05 | -2.46 |
| 2024-07-03 | -2.41 |
| 2024-07-02 | -2.47 |
| 2024-07-01 | -2.40 |